Skip to content

In the BioHarmony Drug Report Database

Decitabine

Dacogen, Decitabine (decitabine) is a small molecule pharmaceutical. Decitabine was first approved as Dacogen on 2006-05-02. It is used to treat myelodysplastic syndromes in the USA. It has been approved in Europe to treat myeloid leukemia. It is known to target cytidine deaminase.
Trade Name Dacogen
Common Name Decitabine
Indication myelodysplastic syndromes, myeloid leukemia
Drug Class Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives
Decitabine
Get full access now